GoodRx Holdings (NASDAQ:GDRX) reported its Q2 earnings results on Monday, August 8, 2022 at 04:07 PM.
Here’s what investors need to know about the announcement.
Earnings
GoodRx Holdings beat estimated earnings by 50.0%, reporting an EPS of $0.06 versus an estimate of $0.04.
Revenue was up $15.16 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.02 which was followed by a 25.86% drop in the share price the next day.
Here’s a look at GoodRx Holdings’s past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | 0.08 | 0.10 | 0.09 | 0.08 |
| EPS Actual | 0.10 | 0.09 | 0.09 | 0.08 |
| Revenue Estimate | 200.44M | 217.46M | 194.89M | 174.68M |
| Revenue Actual | 203.33M | 213.26M | 195.10M | 176.63M |
To track all earnings releases for GoodRx Holdings visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
